HIMS

Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers with licensed healthcare providers and delivers prescription and over-the-counter products directly to customers. Founded in 2017 and headquartered in San Francisco, California, the company provides personalized solutions across multiple categories including sexual health, hair care, dermatology, mental health, and primary care. The platform serves customers in all 50 U.S. states through its digital-first model that integrates virtual consultations, personalized treatment plans, and home delivery of medications and wellness products. Hims & Hers operates separate brands targeting different demographics, with Hims primarily focused on men's health and Hers addressing women's health needs. The company has expanded significantly beyond its initial offerings in erectile dysfunction and hair loss treatments to include GLP-1 weight loss medications, anxiety and depression treatment, and dermatological care. In recent years, Hims & Hers has made strategic moves including building out its own pharmacy fulfillment infrastructure and offering compounded semaglutide injections for weight management. The company went public through a merger with a special purpose acquisition company in January 2021. As of 2024, the platform serves hundreds of thousands of subscribers through its direct-to-consumer model, which emphasizes affordability, convenience, and discretion in healthcare delivery.